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Factors associated with the time to the first wheezing episode
in infants: a cross-sectional study from the International Study
of Wheezing in Infants (EISL)
Rosa M Pacheco-Gonzalez1, Javier Mallol2, Dirceu Solé3, Paul LP Brand4,5, Virginia Perez-Fernandez6, Manuel Sanchez-Solis1,
Luis Garcia-Marcos1,7 and the EISL Study Group8
Male gender, asthmatic heredity, perinatal tobacco smoke exposure and respiratory infections have been associated with wheeze in
the first years of life, among other risk factors. However, information about what factors modify the time to the first episode of
wheeze in infants is lacking. The present study analyses which factors are associated with shorter time to the first episode of
wheeze in infants. Parents of 11- to 24-month-old children were surveyed when attending their health-care centres for a control
visit. They answered a questionnaire including the age in months when a first wheeze episode (if any) had occurred (outcome
variable). The study was performed in 14 centres in Latin America (LA) and in 8 centres in Europe (EU) (at least 1,000 infants per
centre). Factors known to be associated with wheezing in the cohort were included in a survival analysis (Cox proportional hazards
model). Summary hazard ratios adjusted for all risk factors (aHR) were calculated using the meta-analysis approach with random
effects. A total of 15,067 infants had experienced wheezing at least once, out of 35,049 surveyed. Male gender in LA (aHR 1.05,
95% confidence interval (CI) 1.00–1.10, P= 0.047), parental asthma in LA and EU (aHR 1.05, 95% CI 1.00–1.11, P= 0.037), infant
eczema in EU (aHR 1.25, 95% CI 1.12–1.39, Po0.001) and having a cold during the first 3 months in LA and EU (aHR 1.97, 95% CI
1.90–2.04, Po0.001), in LA (aHR 1.98, 95% CI 1.90–2.06, Po0.001) and in EU (aHR 1.91, 95% CI 1.75–2.09, Po0.001) were associated
with a shorter period of time to the first episode. Breast feeding for at least 3 months was associated with a longer period, only in
LA (aHR 0.91, 95% CI 0.86–0.96, Po0.001). Cold symptoms during the first 3 months is the most consistent factor shortening the
time to the first episode of wheezing; breast feeding for ⩾ 3 months delays it only in LA, whereas eczema shortens it only in EU.
Avoiding a common cold in the first months of life could be a good strategy to delay the first wheeze episode; however, cohort
studies will help to elucidate this association.
npj Primary Care Respiratory Medicine (2016) 26, 15077; doi:10.1038/npjpcrm.2015.77; published online 21 January 2016
INTRODUCTION
Wheezing during the first months of life is a very frequent
condition worldwide: 45% of infants who participated in the
International Study of Wheezing in Infants (EISL, ‘Estudio Inter-
nacional de Sibilancias en Lactantes’) had at least one episode of
wheezing and 23% had recurrent wheeze; however, these
prevalences vary between localities.1,2 A considerable number of
surveys have studied the factors associated with wheeze episodes
during the first years of life; however, studies focused on the first
12 months of life are less numerous. Although not every study that
focused on this first year of life addressed the same risk/protective
factors or had the same results, some conclusions can be drawn:
factors such as asthmatic heredity, male gender, perinatal tobacco
smoke exposure, respiratory infections by common viruses,
preterm birth, housing conditions, indoor air quality, outdoor air
pollution, mould stains on household walls, Afro-American
ethnicity and excess infant adiposity3–14 are common risk factors.
Regarding protective factors, breast feeding is by far the most
consistently reported one.9,15
Wheezing during the first months of life might be associated
with later asthma, especially when episodes are severe and/or
frequent.14,16,17 Time to the first episode of wheeze has been
associated with the frequency of recurrence: the earlier the first
episode occurs, the more frequently wheezing recurs.18 It is
possible that some environmental factors could influence the
innate immune response during the first months of life, a critical
period for immune system development, resulting in more
frequent and severe episodes of wheezing.19 However, no study
has been performed to analyse which factors might be associated
with the time to the first episode of wheeze.
In the present paper we perform a survival analysis and present
the results of those factors associated with an earlier or a later
episode of wheezing in a large cohort of 1-year-old infants from
Latin America (LA) and Europe (EU; EISL or International Study of
Wheezing in Infants).
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RESULTS
The total number of infants included in the cohort was 35,049
(mean participation rate 83.5%, range 61–91%). Demographic
features of the whole population has been published elsewhere.2
A total of 15,250 infants had at least one episode of wheeze
during the first 12 months of life; however, information on the age
(months) when it occurred was not available in 183 of them and
these children were excluded from the analysis. Thus, the total
number of infants in the analysis was 15,067. Most infants (99.0%)
were 18 months or younger when parents were surveyed. Figure 1
shows the distribution by age at which children had their first
episode of wheeze, as well as their first cold. In Figure 2 the
proportion of wheezing infants by months is represented. In this
case the whole population had had an attack of wheezing at the
end of the twelfth month. The number of infants included per
centre and the proportion of the studied risk/protective factors are
shown in Table 1. Missing data of each risk/protective factor by
centre are presented in Supplementary Table S1, and the number
of children included in this study and those included in the
multivariate analysis by centre are detailed in Supplementary
Table S2.
Of those factors that have been previously shown to be
significantly associated with wheezing in the present cohort,2 only
male gender (Latin American centres as a group: adjusted hazard
ratio (aHR) 1.05, 95% confidence interval (CI) 1.00–1.10, P= 0.047),
parental asthma (all centres as a group: aHR 1.05, 95% CI
1.00–1.11, P= 0.037), infant eczema (European centres as a group:
aHR 1.25, 95% CI 1.12–1.39, Po0.001) and having a cold during
the first 3 months of life (all centres: aHR 1.97, 95% CI 1.90–2.04,
Po0.001; and also Latin American: aHR 1.98, 95% CI 1.90–2.06,
Po0.001; and European: aHR 1.91, 95%CI 1.75–2.09, Po0.001
centres as groups) were associated with a shorter period of time to
the first wheeze episode. Conversely, exclusive breast feeding for
at least 3 months was significantly associated with a longer period
of time to the first episode only in LA as a group (aHR 0.91, 95% CI
0.86–0.96, Po0.001; Table 2). aHR values of every factor per
centre are shown in Supplementary Table S3.
When taking heterogeneity into account, gender and parental
asthma showed relatively low inconsistency (o50% in general)
both in LA and in EU, although the upper limits of uncertainty
intervals were quite high, and comparison between continents
showed no differences (Q= 1.48, P= 0.224; and Q= 0.01, P= 0.936,
respectively; Table 2). Having a cold during the first 3 months of
life showed high inconsistency (with narrow uncertainty intervals)
both in LA and in EU. Although inconsistent on the size of the
effect, its direction was invariably towards an association with a
shorter time to the first episode (Supplementary Tables S1 and S2).
The association of breast feeding with a longer period to the first
wheeze episode in LA was quite consistent for centres in that
continent (I2 = 35.6%, 95% CI 0–65.6%). The effect of this factor in
the European centres was also consistently (I2 = 0%, 95% CI
0–56.7%) non-influential (Supplementary Tables S1 and S2).
However, the difference between the summary effects in the
two continents reached only marginal significance (Q= 2.53,
P= 0.112). A similar pattern but in the opposite direction was
found for infant eczema: it had a quite consistent association with
a shorter period of time to the first wheeze episode in European
centres but made no difference at all in Latin American centres. In
this case, the difference between continents was highly significant
(Q= 14.3, Po0.001).
DISCUSSION
Main findings
The results of the present study show that only few factors, of
those associated with wheezing in infants during the first years
of life, are associated with a shorter time to the first episode of
wheeze: having a cold in the first 3 months of life, breast feeding
for at least 3 months (but only in Latin American centres) and
eczema (only in European centres). Contrarily, very important risk
factors for wheeze in the first year of life as found in the same
cohort,2 such as mother smoking during pregnancy, parental
rhinitis, attending a nursery school, number of siblings, number of
persons at home and mould stains on household walls, are not
Figure 1. (a) Age (months) at which infants had the first episode of
wheeze (absolute numbers). (b) Age (months) at which infants had
the first episode of cold (absolute numbers). Figure 2. Proportion of wheezing infants by months.
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factors that apparently shorten the period to the first episode.
On the other hand, a consistent protective factor in the Latin
American centres,2 namely, the mother having undergone
university-level education, was not associated with the time to
the first wheeze episode.
Interpretation of findings in relation to previously published work
According to the results of this study the main risk factor to
shorten the period to the first wheeze episode is having a cold in
the first 3 months of life. Despite the high heterogeneity between
the centres, all of them were in the same direction. It seems
reasonable—as has also been shown in the present paper—that
the earlier the first cold the earlier the first wheeze episode.
Certainly, wheeze episodes are mainly triggered by respiratory
viruses20 that cause symptoms similar to those described in the
definition of cold included in the questionnaire used. What our
results seem to indicate is that previous colds without wheeze are
associated with later wheeze episodes.
It is also of interest that parental asthma, although reaching
marginal statistical significance, does not have a substantial
influence on the time to the first wheeze episode. In fact, it is only
in the Latin American centres that a weak association is found,
whereas no association was detected in the European centres. This
finding, together with the lack of influence of parental rhinitis,
might indicate that the lungs of children born in allergic families
behave similarly to those of infants without a family history of
asthma and/or rhinitis, at least until the first wheeze episode. In
other words, newborn lungs would not necessarily be more prone
to suffer from an earlier wheeze episode. Therefore, trying to avoid
respiratory infections during the first months of life may be of
special importance in those infants with a family history of asthma,
as an early episode might have worse consequences than in those
infants without that history.14,16,21,22
Male gender, like parental asthma, reaches marginal statistical
significance only in the Latin American centres; thus, we cannot
conclude that it has an important effect on advancing the
first wheeze episode. Contrarily, male gender is one of the risk
factors reported to be associated with having wheeze episodes
during early childhood.2,8 This would suggest that, although this
respiratory condition is more frequent among boys, gender has no
influence on shortening the time to the first wheeze.
According to the present results, exclusive breast feeding for at
least 3 months might be a good strategy for delaying the first
wheeze episode, but only in Latin American centres. Although our
study could not find an association with breast feeding and a
longer time to the first wheeze episode in European centres,
breast-feeding has been related to reduced wheeze episodes and
should be recommended.2,23 There is no clear explanation for our
results, although it may be related to the type or subtype of
viruses that are responsible for triggering the wheeze episodes,
which might be diverse in different parts of the world,24–26 or to
how the same viruses might circulate differently in different
areas.27 However, breast-feeding has been associated with a lower
risk for viral infections in infants.28 Cohort studies should be
performed in order to elucidate our findings.
Very interestingly, infant eczema was a factor related to a
shorter period of time to the first episode of wheezing, but only in
European centres. These results, based on the summary HR,
are—as breast feeding was—quite consistent among individual
centres. In fact, the summary HR difference between the European
and the Latin American centres is highly significant. It might be
hypothesised that eczema is a marker of atopy and thus
predisposes infant lungs to an earlier wheeze episode. This would
be a reason for finding that the association only in EU due to
asthma is mainly atopic in EU and non-atopic in LA.29 However,
it is currently not so clear-cut as to what extent atopic eczema is
really atopic,30 and parental asthma, as another factor for atopy,31T
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does not shorten, in a very significant way, the time to the first
episode as discussed previously. On the other hand, atopic
eczema has been hypothesised as being related to an imbalance
in the skin microbiome,32 which might be caused in part by the
too frequent use of baths and soaps.33 This bathing is probably—
as an average—more frequent in EU than in LA. In addition, the
present study did not retrieve information as to when the first
flare of eczema started and whether it was before or after the first
wheeze episode, making this association, found only in EU,
difficult to interpret.
Strengths and limitations of this study
The main strengths of this study are the large number of infants
included and the distribution of the centres that agreed to
participate.
However, the present study has several limitations. First, it is a
cross-sectional study and thus only association and not causality
can be inferred from its results. Second, parents were asked about
events that had happened during the previous year; therefore,
some recall bias could be expected. Conditions such as wheeze,
colds or infant eczema were not diagnosed by doctors but
reported by parents answering questions describing symptoms.
Thus, some misclassification could happen, such as upper airway
noises as wheeze. However, questionnaires were validated and are
the only feasible way to acquire information from such a
numerous sample of infants and have been previously used in
large global surveys such as the International Study of Asthma and
Allergies in Childhood.34 No exclusion criteria were applied to
select participants in this study, but conditions that could modify
the time to the first wheeze episode, such as prematurity,
comorbities (congenital heart conditions, complex syndromes and
so on) or admission to a neonatal unit, were not collected. Finally,
a high proportion of mothers with university-level education were
included in the European centres, mainly because the health
centres were in urban areas and this type of population is more
prone to collaborate in studies.
Implications for future research, policy and practice
As the main factor to shorten the time to the first wheeze
episode is having a cold in the first 3 months of life, some
recommendations could be given to those families with allergy
history, which are at higher risk of having wheezing children.
These recommendations should be aimed to prevent respiratory
infections in their children, mainly by avoiding contact with
affected people or avoiding crowded places (for the risk of being
infected). Breast feeding should be recommended, although we
had found an association with longer time to first wheeze only in
LA, as it reduces the risk of an upper respiratory tract infection and
severity.35,36
Conclusions
In summary, the main factor for a shorter period of time to the first
wheeze episode in infants during their first year of life is having
cold symptoms during the first 3 months after birth. Breast
feeding for at least 3 months is associated with a later wheeze
episode only in Latin American centres, whereas infant eczema is
associated with an earlier episode only in European centres.
The causes of the differences between continents remain to be
elucidated.
MATERIALS AND METHODS
A detailed description of the EISL study has been published elsewhere
previously.1,2 In short, all parents of children 11–24 months of age were
invited to participate when attending their health-care centres for their
child’s immunisations or routine health exams. No exclusion criteria were
applied. Parents who accepted answered a retrospective questionnaire of
risk factors and symptoms occurring during the child’s first year of life. This
study was carried out in 14 centres in LA and in 8 centres in EU (mainly
Spain). Samples of at least 1,000 infants were required from participating
centres, providing adequate power to detect a statistically significant
difference of 5% in the prevalence of recurrent wheeze (three or more
episodes) between two centres, with a confidence level of 95%.
Definitions
Wheezing was defined as a positive answer to the question ‘Has your child
had wheezing or whistling in the chest during the first 12 months of
his/her life?’, which had been previously validated in the languages of the
study.37–39 Parental asthma and parental rhinitis were defined as father
and/or mother having the disease as reported by them. Infant eczema was
reported by parents when answering the question ‘Has your child had an
itchy rash, which was coming and going in any area of his/her body, except
around the eyes and nose, and the diaper area, during his/her first
12 months of life?’ Common colds were also reported by parents when
asked whether their babies had had ‘short episodes of cold with runny
nose, sneezing, nasal obstruction, mild cough, with or without mild fever’.
In addition, parents were asked about mother smoking during the child’s
pregnancy (yes/no); infant attending nursery school during the first year of
life (yes/no); exclusive breast feeding (more than 3 versus 3 or fewer
months); number of siblings, number of persons living in the same
household, existence of mould stains on the walls and presence of pets at
the time the questionnaire was taken; maximum study level achieved by
the mother (primary/secondary versus university); and ethnicity (Afro-
American versus Caucasian).
The outcome variable was defined as the answer to the question
‘At which age has your child had the first episode of wheezing or whistling
in the chest?’ (in months).
Data analysis
Known statistically significant risk factors for wheezing in the first year of
life in the present cohort2 and defined above were tested for their
association with a shorter or longer period of time from birth to the first
wheeze episode. With respect to smoking, a high colineality between
smoking during pregnancy by the mother and afterwards was found; thus,
only smoking in pregnancy was included in the analyses. This was
performed within each centre by means of a survival analysis, using the
Cox proportional hazards model test, in order to obtain HR and their
respective 95% CI (Stata v7, College Station, TX, USA). A crude HR and an
aHR for the remaining factors were calculated for each factor. Only those
infants having at least one episode of wheezing were entered in this
analysis, as our aim was to know the factors associated with a shorter time
to the first wheeze episode, and thus no interest existed in including those
who did not wheeze. Moreover, a previous analysis including the whole
sample (those who wheezed and those who did not) was performed in
order to know the factors associated with wheezing,2 which were the
factors tested in the current analysis. Ethnicity was only included in those
centres with at least 5% of the individuals being of Afro-American origin
(centres from Brazil, Colombia, El Salvador and Honduras).
Summary HR and aHR with 95% CIs were calculated using the meta-
analysis approach with random effects in order to allow for the weight of
the centre40 by means of CMA v2.2 software (Borenstein M, Hedges L,
Higgins J, Rothstein H; Comprehensive Meta-analysis Version 2, Biostat,
Englewood, NJ, USA, 2005). Summary aHRs were calculated for all centres
and also for centres of LA and EU separately, and differences between
continents were compared by means of the Cochran Q test. The I2 statistic
was used to assess the percentage of heterogeneity for every summary
aHR. Twenty-five, fifty and seventy-five percent were considered as
cutoff points for low, medium and high heterogeneity, respectively.41
A Kaplan–Meier curve was performed to represent the proportion of
wheezing infants by age.
Ethical approval
The study was approved by the local Scientific Ethic Committee at each
centre, and parents or guardians answered the questionnaire after
providing their fully informed written consent. The data set was
anonymised.
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